Definium Therapeutics, Inc. (DFTX)
38.81
+0.13
(+0.34%)
USD |
NASDAQ |
Sep 18, 16:00
39.15
+0.34
(+0.88%)
Pre-Market: 08:02
Definium Therapeutics Net Income (TTM) : -353.78M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -353.78M |
| March 31, 2026 | -237.54M |
| December 31, 2025 | -183.79M |
| September 30, 2025 | -168.10M |
| June 30, 2025 | -114.52M |
| March 31, 2025 | -77.63M |
| December 31, 2024 | -108.68M |
| September 30, 2024 | -97.80M |
| June 30, 2024 | -102.04M |
| March 31, 2024 | -125.32M |
| December 31, 2023 | -95.73M |
| September 30, 2023 | -76.77M |
| June 30, 2023 | -75.33M |
| March 31, 2023 | -63.16M |
| December 31, 2022 | -56.80M |
| September 30, 2022 | -70.64M |
| June 30, 2022 | -71.35M |
| March 31, 2022 | -99.64M |
| Date | Value |
|---|---|
| December 31, 2021 | -96.04M |
| September 30, 2021 | -91.21M |
| June 30, 2021 | -82.69M |
| March 31, 2021 | -43.15M |
| December 31, 2020 | -35.34M |
| September 30, 2020 | -22.08M |
| June 30, 2020 | -13.57M |
| March 31, 2020 | -8.023M |
| August 31, 2019 | -1.116M |
| May 31, 2019 | -0.6766M |
| February 28, 2019 | -0.7425M |
| November 30, 2018 | -0.8184M |
| August 31, 2018 | -0.8576M |
| May 31, 2018 | -1.155M |
| February 28, 2018 | -1.332M |
| November 30, 2017 | -1.367M |
| August 31, 2017 | -1.520M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Enliven Therapeutics, Inc. | -105.93M |
| Cocrystal Pharma, Inc. | -9.938M |
| CNBX Pharmaceuticals, Inc. | -0.4621M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 9.30M |